Renee P. Tannenbaum, Director at Cardiff Oncology, Inc. (CRDF), bought 10,000 shares at $1.72 ($17K) on 2022-09-15, disclosed to the SEC on 2022-09-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.72 | 3,600 | $6K | 36.0% |
| 2 | $1.72 | 6,400 | $11K | 64.0% |
| Total | $1.72 avg | 10,000 | $17K | 100% |
| Filing → |
| ANIP | SELL | 2024-05-17 | $128K | — | Filing → |
| ZGNX | SELL | 2021-11-30 | $124K | — | Filing → |
| ZGNX | BUY | 2021-06-03 | $85K | — | Filing → |